Ubs Group Ag Pacific Biosciences Of California, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 642,849 shares of PACB stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

642,849

Previous 829,134 22.47%

Holding current value

$1.24 Million

Previous $1.14 Million 3.79%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.2 - $2.17 $223,542 - $404,238	-186,285 Reduced 22.47%	642,849 $1.09 Million
Q2 2024 Aug 13, 2024	BUY	$1.36 - $3.65 $206,558 - $554,365	151,881 Added 22.43%	829,134 $1.14 Million
Q1 2024 May 13, 2024	BUY	$3.52 - $9.59 $2.26 Million - $6.17 Million	643,359 Added 1898.15%	677,253 $2.54 Million
Q4 2023 Feb 09, 2024	BUY	$5.97 - $10.36 $67,144 - $116,518	11,247 Added 49.66%	33,894 $332,000
Q3 2023 Nov 09, 2023	SELL	$8.23 - $13.93 $1.71 Million - $2.89 Million	-207,435 Reduced 90.16%	22,647 $189,000
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $1.93 Million - $2.72 Million	193,508 Added 529.09%	230,082 $3.06 Million
Q1 2023 May 12, 2023	SELL	$7.94 - $12.02 $129,112 - $195,457	-16,261 Reduced 30.78%	36,574 $423,000
Q4 2022 Feb 08, 2023	SELL	$5.67 - $11.2 $155,074 - $306,320	-27,350 Reduced 34.11%	52,835 $432,000
Q3 2022 Nov 10, 2022	BUY	$3.93 - $8.57 $159,377 - $347,547	40,554 Added 102.33%	80,185 $465,000
Q2 2022 Aug 10, 2022	SELL	$4.02 - $10.43 $231,515 - $600,674	-57,591 Reduced 59.24%	39,631 $175,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $23,266 - $57,683	-2,760 Reduced 2.76%	97,222 $885,000
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $184,318 - $287,865	-9,570 Reduced 8.74%	99,982 $2.05 Million
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $1.14 Million - $1.6 Million	-45,756 Reduced 29.46%	109,552 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$22.3 - $36.02 $1.53 Million - $2.46 Million	68,428 Added 78.76%	155,308 $5.43 Million
Q1 2021 May 12, 2021	BUY	$26.38 - $51.15 $105,414 - $204,395	3,996 Added 4.82%	86,880 $2.89 Million
Q4 2020 Feb 11, 2021	BUY	$10.5 - $28.5 $473,329 - $1.28 Million	45,079 Added 119.24%	82,884 $2.15 Million
Q3 2020 Nov 12, 2020	BUY	$3.61 - $9.87 $11,425 - $31,238	3,165 Added 9.14%	37,805 $373,000
Q2 2020 Jul 31, 2020	SELL	$2.65 - $4.03 $299,031 - $454,753	-112,842 Reduced 76.51%	34,640 $119,000
Q1 2020 May 01, 2020	SELL	$2.36 - $5.26 $2.39 Million - $5.33 Million	-1,013,463 Reduced 87.3%	147,482 $451,000
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $1.95 Million - $2.36 Million	-424,207 Reduced 26.76%	1,160,945 $5.97 Million
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $323,641 - $399,525	-64,858 Reduced 3.93%	1,585,152 $8.18 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $606,894 - $759,643	102,516 Added 6.62%	1,650,010 $9.98 Million
Q1 2019 May 14, 2019	SELL	$6.8 - $7.4 $2.53 Million - $2.75 Million	-371,679 Reduced 19.37%	1,547,494 $11.2 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $5.7 Million - $11.2 Million	1,428,246 Added 290.93%	1,919,173 $14.2 Million
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $352,390 - $555,616	100,111 Added 25.62%	490,927 $2.66 Million
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $187,979 - $349,232	89,090 Added 29.53%	390,816 $1.39 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $260,579 - $410,571	127,112 Added 72.8%	301,726 $619,000
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $260,779 - $547,737	-100,687 Reduced 36.57%	174,614 $461,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $518,611 - $902,707	162,066 Added 143.12%	275,301 $1.45 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-266 Reduced 0.23%	113,235 $403,000
Q1 2017 Nov 14, 2017	BUY	N/A	113,501	113,501 $586,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $434M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account